immunogen logo
「immunogen logo」熱門搜尋資訊
「immunogen logo」文章包含有：「ImmunoGen」、「ImmunoGen」、「StockInformation」、「ImmunoGenisnowpartofAbbVie」、「AbbVietoAcquireImmunoGen」、「PressReleases」、「Financials&Filings」、「AbbVieCompletesAcquisitionofImmunoGen」、「ImmunoGenIncCompanyProfile」
查看更多
ImmunoGen
https://www.immunogen.com
Target a better now with ImmunoGen, Inc., a biotechnology company focused on the development of antibody-drug conjugate (ADC) technology to treat cancer.
ImmunoGen
http://investor.immunogen.com
ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with ...
Stock Information
https://investor.immunogen.com
ADA Statement and Inquiries. ImmunoGen Logo. Contact Us · Privacy Notice · Consumer Health Data Privacy Notice; Cookies Settings; Your Privacy Choices privacy ...
ImmunoGen is now part of AbbVie
https://www.abbvie.com
ImmunoGen is now part of AbbVie ... Together we will be working to make a remarkable impact for cancer patients and their communities of care, raising standards ...
AbbVie to Acquire ImmunoGen
https://investor.immunogen.com
(NASDAQ: IMGN) today announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship cancer therapy ELAHERE® ( ...
Press Releases
https://investor.immunogen.com
ImmunoGen Logo. Contact Us · Privacy Notice · Consumer Health Data Privacy Notice; Cookies Settings; Your Privacy Choices privacy · Usage Policy. © 2024 ...
Financials & Filings
https://investor.immunogen.com
ADA Statement and Inquiries. ImmunoGen Logo. Contact Us · Privacy Notice · Consumer Health Data Privacy Notice; Cookies Settings; Your Privacy Choices privacy ...
AbbVie Completes Acquisition of ImmunoGen
https://investor.immunogen.com
AbbVie and ImmunoGen's combined capabilities represent an opportunity to deliver potentially transformative ADC therapies to patients.
ImmunoGen Inc Company Profile
https://www.globaldata.com
ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of novel antibody-drug conjugates (ADCs) that facilitate ...